Charles J. Link Jr.

Biography

Charles J. Link Jr., MD, co-founded NewLink Genetics in 1999 with the idea of leveraging the body’s immune system to fight cancer. Dr Link’s scientific leadership in the field of immuno-oncology and focus on the IDO pathway in cancer therapy has led to the development of NewLink’s IDO inhibitors. He is Chief Executive Officer, Chief Scientific Officer, and Chairman of the Board of Directors. Dr Link was appointed by United States Senator John Glenn of Ohio to the United States Air Force Academy where he studied chemistry. Prior to graduating, he was accepted to a special program at Stanford University School of Medicine in Stanford, California, where he received his bachelor’s degree. Dr Link interned at the University of California, San Francisco, and completed his residency and fellowship training in medical oncology at the National Cancer Institute in Bethesda, Maryland, where he also served as an attending physician.  

Research Interest

Medical Oncology and Hematology